Abstract Submission Information

Key Dates

Late-Breaking Abstract Criteria & Eligibility

IMPORTANT – Please read the guidelines below before submitting an abstract

ONLY the presenting author is allowed to submit the abstract

Submission Procedure

Submission Regulations

1. The person submitting the abstract will automatically be the Presenting Author and the corresponding author.
   • If the presenting author is an APSR member, please provide the same email address from which you received your membership number information.
2. The presenting authors must be one of the co-authors of the submitted abstract.
3. There is no limit on how many abstracts can be submitted by a single presenting author.
4. Abstracts must be submitted electronically through the online abstract submission platform.
5. The presenting authors must ensure that all authors have given their consent to be listed as co-authors on the submitted abstract.
   • Authorship and author order should be agreed upon by all authors.
6. The presenting authors are required to complete a Declaration of Conflict of Interest. Abstracts supported in whole or in part by tobacco or tobacco-related industry will not be accepted.
7. The presenting authors must specify their own sponsoring entity in addition to that of all co-authors.
8. The presenting author must ensure that the contents of the abstract do not infringe the copyright and any other rights of any third party.
9. The presenting authors must choose one category for each abstract from the following:
   1. Clinical Respiratory Medicine
   2. Cell and Molecular Biology
   3. Clinical Allergy and Immunology
   4. Environmental & Occupational Health and Epidemiology
   5. Respiratory Infections (non-tuberculous)
   6. Tuberculosis
   7. COPD
   8. Lung Cancer
   9. Asthma
   10. Respiratory Neurobiology and Sleep
   11. Critical Care Medicine
   12. Bronchoscopy and Interventional Techniques
   13. Paediatric Lung Disease
   14. Respiratory Structure and Function
   15. Pulmonary Circulation
   16. Interstitial Lung Disease
10. The presenting authors may request their preferred presentation method as oral, poster, or either. Please be reminded that the Scientific Programme Committee will take the request into consideration but will ultimately decide which method will be allocated to the abstract.
11. Submission of closely related abstracts from the same group is discouraged.
12. Splitting of a body of work into multiple abstracts is discouraged and consolidation into one abstract is preferred.
13. Submission and presentation of abstracts are subject to the principle of no duplication or plagiarism in publications. Breaching of such rules will lead to rejection of submission or presentation at the Congress without refund of registration fee. All decisions are final with the Central and Local Congress Committee.
14. If identical abstracts are found to be submitted, only the abstract on the latest date of the submission will be considered for evaluation without prior notice.
15. The presenting authors are responsible for the accuracy of all contents of the abstract.
16. By submitting the abstract, the presenting authors confirm that the presented study meets the ethical guidelines for research and publication, including the legal requirements of the country in which the study was conducted.

Encore Abstracts

1. Submissions of encore abstracts are NOT allowed. If encore abstracts are found to be submitted, the abstracts shall be rejected without prior notice.
2. The presenting authors must declare during the submission that the material in the presentation is original and that it will not be published or presented elsewhere before the APSR 2025 Congress.
3. Authors can submit the same abstracts or findings to other events but MUST WITHDRAW the abstracts if they are presented and published before the APSR Congress.
4. Authors can submit findings which are published in the supplement of Respirology to other journals but are required to disclose the prior abstract publication to the journal they are submitting to. However, the following will be regarded as an encore abstract in the supplement of Respirology and the abstract will need to be withdrawn:
   An author submits the findings to the congress as an abstract, and simultaneously submits the same findings to Respirology/other journals as a full paper, which is then accepted by Respirology/other journals and published before the Congress.

Format and Content

1. Language: English ONLY
   Abstracts that contain non-English words/characters shall be rejected without prior notice.
2. Authors:
   • The abstract is limited to a maximum of 15 co-authors per abstract.
   • Authors' names should be provided in: ⇒ Example:
     (Correct) John Smith
     (Incorrect) John S. / J. Smith / JOHN SMITH
     • initial capital/lower case, NOT all capital/lower case.
     • full name, in 'Given name Family name' order.
   • Post-nominal/degrees are NOT required.
3. Affiliation
   • The 1^st author's affiliation should be listed first.
   • Department/Faculty/Division, Institution, City, Country/Region must be provided in each corresponding field.
   • Full name of the author's institution must be provided.
     ⇒ Example:
     (Correct) Asian Pacific Hospital
     (Incorrect) AP Hospital
   • If authors do not have fixed affiliations, provide the affiliation where the work was conducted and/or the patient was treated.
   • Job position/role (e.g. Registrar, Trainee, etc.) should not be included in affiliations.
4. Title:
   • The abstract title should be less than 25 words.
   • Capitalize the first letter of the title only (do not use all caps). *exception: unique words
     ⇒ Example:
     (Correct) The solution to air pollution
     (Incorrect) THE SOLUTION TO AIR POLLUTION
5. Abstract Structure:
   Abstracts that do not comply with the size requirement and structure may be rejected without prior notice.
   • The abstract body must be less than 300 words.
   • The following are excluded from the word count:
     • Title
     • Author / Affiliation information
     • Keywords in the "Keywords" field
     • Acknowledgements/Disclosure Statement
     • Figure/Table
     • Sub-headings
   • The abstract must have the following sub-headings depending on the abstract type:
     • Original Research: Background and Aims - Methods – Results – Conclusion
     • Case Report: Introduction - Case Report – Discussion
     • Trial in Progress(TiP) Abstract: Background – Methods  #Trial in Progress (TiP) Abstract
   • Abbreviations must be defined in parentheses on the first mention in the text.
6. Keywords
   Keywords should be limited to THREE and provided in each corresponding field.
   Abbreviations should be avoided in the keywords list.
7. References:
   • References are discouraged and should be limited to THREE.
   • Any references should be numbered in the text and listed immediately below the text in the following format:
     • Authors, Journal, Year, Volume, First and Last Pages
       ➡Example: (Smith N et al, Respirology, 2024, 29, 951-961)

• References that don’t follow the required format will be removed without prior notice.
• References are included in the word count limit for the abstract body.

1. Acknowledgements/Disclosure Statement:
   Any Acknowledgements or Disclosure Statement should be listed in each corresponding field if any.
2. Case Report:
   • A case report should describe only a single case and contain a description of the actual case, and a discussion of the novelty and importance of the specific case.
   • A case report must have the designated sub-headings. (See Format and Content - #5 Abstract Structure in the Abstract Submission Guideline)
3. Systematic Review and meta-analysis:
   • Systematic reviews that include clear questions and scientific analysis such as meta-analysis CAN be submitted.
   • Systematic reviews and meta-analysis must have the same sub-headings as the Original Research. (See Format and Content - #5 Abstract Structure in the Abstract Submission Guideline)
4. Literature review
   A literature review abstract can NOT be submitted.
5. Trial in Progress (TiP) Abstract
   A TiP abstract CAN be submitted. See the section "Trial in Progress (TiP) Abstract"

Figure/Table

A Figure and table that do not comply with the requirements and are considered inappropriate may be removed without prior notice.
(See "Unacceptable Figure/Table" in this section)

1. Inclusion of tables and figures is discouraged and should be limited to a maximum of 1 figure or 1 table.
2. The figures should be limited to a single graph or image – figures containing multiple graphs or images will not be published with the abstract.
3. Author headshots/group shots are not appropriate figures and will not be published.
4. Any patient personal data/information and image in the figure/table must be de-identified. Failure to do so may result in rejection of the abstract or removal of the figure/table without prior notice.
5. If a table or figure is included, it must be cited in the abstract text.
6. Figures must be sharp, and all text must be legible.
7. Format: JPG or JPEG format ONLY - Extension should be .jpg / .jpeg
8. Recommended size for optimal resolution:
   • Tables: up to 5 columns x 8 row mx-0s (larger tables will not be published)
   • Figures: a minimum resolution of 300 dpi and a minimum width of 169 mm
9. Maximum file size: 20MB
10. Filename: Alphanumeric characters ONLY
11. When including a table, it is recommended to save the table as an image before uploading it.

Unacceptable Figure/Table

E-Mail Notification

1. Correspondence relating to the abstract will be sent to the presenting author's email address provided in the online submission platform.　　　
2. Check both your inbox and junk mail folder for email notifications.
3. If your email settings only allow emails from specific domains and addresses, it may prevent the email from entering your inbox. Please check to ensure that your settings allow emails from:
   apsr2025@philchest.org.ph / @philchest.org.ph

Confirmation on Receipt of Submission / Edit / Withdraw

1. A confirmation e-mail will be sent to the presenting author with Abstract ID from APSR 2025 Manila Secretariat apsr2025@philchest.org.ph upon receipt of your submission / Edit / Withdraw.
2. If the presenting author does not receive the confirmation email within 24 hours, please contact apsr2025@philchest.org.ph.
3. Please keep the confirmation e-mail for future reference until receipt of the result notification.

Result Notification

ONLY the presenting author will be notified of the abstract submission status, session formats, and scheduling of presentations by the APSR 2025 Manila Secretariat apsr2025@philchest.org.ph by mid-June 2025 (Regular Abstract Submission) / by end of July 2025 (Late-Breaking Abstract Submission). The presenting authors are responsible for informing all co-authors about the status of their submitted abstracts.

Payment of Registration fee

1. The presenting authors of the accepted abstracts must register for the congress and complete the payment of the registration fee before the "cutoff" date. The cutoff date will be stated in the acceptance letter.
2. No registration of the accepted abstract's presenting author for the Congress before the "cutoff" date will result in losing eligibility for presenting at the Congress without prior notice. (The cutoff date will be stated in the acceptance letter)
3. APSR members can get a discount on the registration fee.
   When registering for the Congress at the APSR membership rate as the accepted abstract presenter, an active APSR membership is required at the time of registration. Expired or application-in-progress membership will be regarded as "having no APSR membership".
   If the presenting authors do not have an APSR membership, it is strongly recommended to apply for the membership before receiving the result notification as the membership application takes time.
   • To apply for the APSR membership, please visit https://apsr.org/members/join/
   • To enquire about your APSR membership status and number, please contact member@apsr.org

Publication of Abstracts

1. Only abstracts presented during the Congress will be published in a supplement of Respirology, known as the Abstract Supplement.
2. For abstracts that are accepted for presentation, the contents including names of authors, will be published as they appear in the submitted abstract in the Abstract Supplement.
3. The copyright of individual abstracts in the Abstract Supplement remains with the author.
4. Authors of accepted abstracts are expected to comply with the Ethical Considerations outlined in Respirology's Author Guidelines. (https://onlinelibrary.wiley.com/page/journal/14401843/homepage/ForAuthors.html#Policy).
5. Authors must agree that their abstracts may be published on the Congress website or elsewhere, either prior to or during the Congress, as well as in a supplement of Respirology that may be distributed electronically.
6. The APSR reserves the right to remove from any publication any abstract that does not comply with the hereinabove.

Abstract Awards and Application

1. ONLY the presenting authors who are first authors are eligible to apply for any awards.
2. Application for abstract awards must be made online at the time of abstract submission.
3. Award-winning abstracts are selected among abstracts submitted only during the regular submission period, NOT during the late-breaking abstract submission period.
4. In case a presenting author of the award-winning abstract does not present the abstract onsite at the Congress, the award will be cancelled.

Changes and Withdrawals

1. A submitted abstract can be edited at any time until the abstract submission deadline. Please login to the online abstract submission platform, select the abstract title to make changes and click "Submit" after edited.
2. If you wish to change the presenting author or withdraw your abstract AFTER receiving the acceptance notification, please contact the APSR 2025 Manila Secretariat (apsr2025@philchest.org.ph) no later than 31 July 2025.

Additional Information

1. All abstracts are evaluated anonymously by the relevant Assembly leaders and liaisons from the Local Congress Committee based on the following 3 main criteria (on a scale of 1 to 5):
   - Originality
   - Scientific Validity
   - Clinical Impact
2. The Scientific Committee reserves the right to accept or reject an abstract.
3. To view APSR's privacy policy, please visit: APSR 2025 - Privacy Policy

Abstract Presentation

The presenting authors are required to include an APSR Disclosure form when presenting the abstract. The Disclosure form will be provided to presenting authors of accepted abstracts after result notification.

• Oral abstract presenter: Include the APSR Disclosure slide next to the cover slide.
• Poster abstract presenter: Decorate the APSR Disclosure form above the poster.

Trial in Progress (TiP) Abstract

1. General Guidelines:
   • Clinical trials in all phases (I to III) can be submitted for consideration of presentation.
   • All abstracts submitted as TiP abstracts must be ongoing studies and have not reached pre-specified endpoints for analysis.
   • Enrollment must have already begun or have been completed with no data analysis available by the abstract submission deadline.
2. Encore TiP Abstract:
   Submissions of encore TiP abstracts are NOT allowed. The author can submit only TiP abstracts that include unpublished data and contents.
3. Copyright of TiP Abstract:
   • The copyright of individual TiP abstracts in a supplement of Respirology remains with the author.
   • Authors are responsible to declare their submissions will not infringe on copyright of previous abstract publication on other Conferences including and not limited to previous APSR Congresses.
   • If the copyright has been assigned to another entity, the presenting author must obtain permission from the copyright holder for APSR to publish the abstract in a supplement of Respirology, known as the Abstract Supplement, and APSR retains the sole right to check, and to accept or publish that abstract, or any such abstract with uncertain copyright clearance, in APSR Congress or relevant publications.
4. Abstract Structure:
   The TiP abstract MUST have the following sub-headings:
   • Background
     • Scientific background/rationale for the trial
     • Related studies of particular interest
   • Methods
     • Trial design and statistical methods
     • Treatment or intervention planned
     • Clinical trial registry number
     • Major eligibility criteria
5. What is NOT accepted in the TiP Abstract:
   • The inclusion of results (completed trials) or preliminary data
   • The inclusion of brand and proprietary drug names

New Abstract Submission Log in My Page

Withdraw